Delisting riskPopularity #4,570
RDHL · NASDAQ · Drug Manufacturers - Specialty & Generic

RedHill Biopharma (ADR) (RDHL)

Specialty biopharmaceutical developer behind Talicia and a partner-led oral-medicine pipeline.

$0.5304
vs last close−0.01 (−1.96%)

Something off on this page? Send us feedback.

EPSReportedEstimate

Jun '23Nov '23Mar '24Apr '24Jul '24Oct '24Apr '25Sep '25
Reported$4.83−$24.00−$0.20−$1.00−$2.00−$1.00−$1.00−$1.00
Estimate$1.19$1.39−$0.03−$0.30−$690.00−$690.00−$690.00
Surprise+305.9%−1,826.6%−566.7%−566.7%+99.9%+99.9%+99.9%

RevenueReportedEstimate

Jun '23Nov '23Mar '24Apr '24Jul '24Oct '24Apr '25Sep '25
Reported$1.8M$567.5K$567.5K$1.3M$1.3M$2.7M$2.0M$2.0M
Estimate$2.1M$24.2M$25.7M$25.7M$25.7M$4.4M$4.4M$4.4M
Surprise−15.0%−97.7%−97.8%−95.0%−95.0%−37.5%−53.4%−53.4%

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Sep 2029$0.00
Jun 2029$0.00
Mar 2029$0.00
Dec 2028$0.00
Sep 2028$0.00
Jun 2028−$10.00
Mar 2028−$20.00
Dec 2027−$10.00
Sep 2027−$20.00
Jun 2027−$300.00
Mar 2027−$433.33
Dec 2026−$474.29
Sep 2026−$352.86
Aug 2026−$435.00
Mar 2026−$435.00
Mar 2026−$435.00
Sep 2025−$690.00
Sep 2025−$690.00−$1.00+99.9%
Apr 2025−$690.00−$1.00+99.9%
Apr 2023−$690.00−$1.00+99.9%
Oct 2024−$690.00−$1.00+99.9%
Jul 2024
Apr 2024
Mar 2024
Nov 2023
Jun 2023
Jun 2023
Mar 2023
Nov 2022
Sep 2022
Jun 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Jul 2019
May 2019
Feb 2019
Nov 2018
Aug 2018
May 2018
Feb 2018
Nov 2017
Jul 2017
May 2017
Feb 2017
Nov 2016
Jul 2016
Apr 2016
Feb 2016
Nov 2015
Jul 2015
Apr 2015

The latest year is open to everyone — the 38 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Sep 2029$0.00$25.7M
Jun 2029$0.00$24.2M
Mar 2029$0.00$23.5M
Dec 2028$0.00$22.8M
Sep 2028$0.00$23.5M
Jun 2028−$10.00$22.8M
Mar 2028−$20.00$18.1M
Dec 2027−$10.00$18.5M
Sep 2027−$20.00$21.5M
Jun 2027−$300.00$23.6M
Mar 18, 2027−$433.33$24.1M
Dec 2026−$474.29$24.5M
Sep 2026−$352.86$24.3M
Aug 31, 2026−$435.00$22.7M
Mar 30, 2026−$435.00$22.7M
Mar 12, 2026−$435.00$22.7M
Sep 2025−$690.00$4.4M
Sep 5, 2025−$690.00−$1.00+99.9%$4.4M$2.0M−53.4%+0.7%
Apr 10, 2025−$690.00−$1.00+99.9%$4.4M$2.0M−53.4%+3.0%
Apr 28, 2023−$690.00−$1.00+99.9%$18.1M$12.8M−29.3%−8.0%
Oct 3, 2024−$690.00−$1.00+99.9%$4.4M$2.7M−37.5%+1.4%
Jul 30, 2024
Apr 8, 2024
Mar 14, 2024
Nov 6, 2023
Jun 30, 2023
Jun 12, 2023
Mar 15, 2023
Nov 7, 2022
Sep 23, 2022
Jun 23, 2022
Mar 17, 2022
Nov 30, 2021
Aug 26, 2021
May 27, 2021
Mar 18, 2021
Nov 12, 2020
Aug 13, 2020
May 27, 2020
Mar 4, 2020
Nov 19, 2019
Jul 23, 2019
May 7, 2019
Feb 26, 2019
Nov 13, 2018
Aug 30, 2018
May 8, 2018
Feb 22, 2018
Nov 13, 2017
Jul 25, 2017
May 3, 2017
Feb 23, 2017
Nov 14, 2016
Jul 26, 2016
Apr 20, 2016
Feb 25, 2016
Nov 9, 2015
Jul 29, 2015
Apr 30, 2015

The latest year is open to everyone — the 38 quarters behind it read with an account.